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SHORT REPORTS
High-Quality and -Quantity DNA Extraction
from Frozen Archival Blood Clots for Genotyping
of Single-Nucleotide Polymorphisms
Steffen Bank,1,2 Bjørn Andersen Nexø,2 Vibeke Andersen,1,3,4
Ulla Vogel,5,6 and Paal Skytt Andersen7
Background: The recovery of biological samples for genetic epidemiological studies can be cumbersome. Blood clots
are routinely collected for serological examinations. However, the extraction of DNA from blood clots can be
difficult and often results in low yields. Aim: The aim was to compare the efficiency of commercial purification kits
for extracting DNA from long-term frozen clotted blood. Methods: Serum tubes with clotted blood were stored at
- 20C for 1 to 2.5 years before DNA extraction. DNA was extracted from 10 blood clot samples using PureGene
(Qiagen) with and without glycogen, the QIAamp DNA Micro kit (Qiagen), and the Nucleospin 96 Blood kit
(Macherey-Nagel). Furthermore, blood clots from 1055 inflammatory bowel disease patients were purified using
the Maxwell 16 Blood purification kit (Promega). The DNA was extracted according to the manufacturers‘ in-
structions and real-time PCR and the A260/A280 ratio were used to evaluate the quality of the extracted DNA.
Results: The highest DNA yield was obtained by the Maxwell 16 Blood purification kit (Promega) with a median of
4.90mg (range 0.8–25mg) pr 300mL total blood. PureGene with glycogen (Qiagen) had the second highest yield with
a median of 0.65mg (range 0.5–2.6mg) pr 300mL total blood. Conclusion: The yield obtained by the different
commercial kits varied considerably. Our work demonstrates that high-quality and -quantity DNA can be ex-
tracted with the Maxwell 16 Blood purification kit (Promega) from cryopreserved blood clots, even after prolonged
storage. The recovered DNA served as a reliable PCR template for single-nucleotide polymorphism assays.
Introduction
Epidemiological studies often require many partici-pants and the recovery of biological samples can be
cumbersome.
A highly neglected source of DNA potentially useful for
genetic studies is the blood clot remaining in serum tubes
from blood samples routinely collected for serum chemistry
examinations or for recovery of mononuclear cells. Recovery
of DNA from the blood clot is a significant challenge due to
troublesome handling and suboptimal outcome (Niku et al.,
1987; Iovannisci et al., 2006; Se Fum et al., 2007; Xu et al., 2010;
Lundblom et al., 2011).
In clinical laboratories, blood clots are normally discarded
after serological and viral testing (Adkins et al., 2002; Xu et al.,
2010). If DNA could easily be extracted with high yield from
long-term frozen serum tubes, the storage of blood clots in
serum tubes could be a convenient method for collecting
DNA for retrospective studies without collection of additional
blood samples.
In this study, we compared the efficiency of four com-
mercially available kits for extracting DNA from frozen ar-
chived clotted blood.
Materials and Methods
Test samples
Blood samples were sent to the Statens Serum Institut
(SSI) in two 10-mL serum-separation tubes from Danish
hospitals intended for tuberculosis quantiferon testing
(Cellestis). The blood was collected at SSI from 01.09.2009
to 30.03.2011. Blood from 9217 patients were collected and
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1055 of the blood samples were from patients with in-
flammatory bowel disease. The residual blood was frozen
at - 20C and DNA was extracted in February 2012.
DNA extraction
Four different commercial purification kits were used to
extract DNA from different volumes of the coagulated blood
samples as shown in Table 1:
(1) Maxwell 16 Blood purification kit (Promega), (2) Pure-
Gene (Qiagen) with and without glycogen, (3) QIAamp DNA
Micro kit (Qiagen), and (4) Nucleospin 96 Blood kit
(Macherey-Nagel). The frozen blood clot was thawed at room
temperature for 15min and 100 to 300mL total blood was
extracted (Table 1) without being homogenized or otherwise
pretreated. The DNA was extracted according to the manu-
facturers‘ instructions and dissolved in ddH2O.
DNA yield and quality
Two microliter purified DNA was used to measure the
DNA concentration and the purity (A260/A280) of the extrac-
tions by NanoDrop-1000 (Thermo Scientific).
The extracted DNA was genotyped by KBioscience and
48 samples were used for genome-wide screen on Im-
munochip, an Illumina Infinium genotyping chip containing
196 524 polymorphisms (718 small insertion deletions, 195
806 single-nucleotide polymorphisms [SNPs]) (Institute of
Clinical Molecular Biology, Kiel, Germany).
The SNPs genotyped by KBioscience were TLR2 (rs4696480,
rs1816702, rs11938228, rs3804099), TLR4 (rs12377632, rs5030728,
rs1554973), LY96 (MD-2) (rs11465996), CD14 (rs2569190), TLR5
(rs5744168), TLR9 (rs187084, rs352139), TNFA (TNF-a) (rs180
0629, rs1800630, rs1799724, rs361525), TNFRSF1A (rs4149570),
TGFB1 (rs1800469), IL1B (rs1143623, rs4848306, rs1143627),
IL1RN (rs4251961), IL4R (rs1805010), IL6 (rs10499563), IL6R
(rs4537545), IL10 (rs1800872, rs3024505), IL17A (rs2275913),
IL23R (rs11209026), PTPN22 (rs2476601), PPARG (rs1801282),
NFKB1 (rs28362491), NFKBIA (IkBa) (rs696, rs17103265),
SUMO4 (rs237025), TNFAIP3 (rs6927172), MAP3K14 (rs722
2094), IFNG (rs2430561), and NLRP3 (rs4612666).
Statistical analysis
An independent t-test was used to determine whether the
yield of DNA from blood samples cryopreserved 2 to 2.5
years differed from blood samples cryopreserved 1 to 1.5
years and to compare the yield from the four purification
kits. Statistical analysis was performed using STATA version
11 (STATA Corp.).
Results
DNA yield
The DNA yields by the different purification kits are shown
in Table 1. The highest yields were obtained using the Max-
well 16 Blood purification kit with a median of 4.9 mg (range
0.8–25 mg) pr 300 mL total blood followed by PureGene with
glycogen with amedian of 0.65 mg (range 0.5–2.6mg) pr 300mL
total blood ( p < 0.001).
DNA quality
High-quality DNA was obtained with the different purifi-
cation methods as shown by the A260/A280 ratio and real-time
PCR (Table 1).
Genotyping results
The number of correct calls was > 99% for all of the ex-
traction methods as described in Table 1. In a pilot study, 48
DNA samples purified by the Maxwell 16 Blood purification
kit were hybridized to an Illumina Infinium genotyping chip
demonstrated that both quantity and quality of the DNAwere
sufficiently high to allow for genome-wide studies (personal
communication).
Length of storage
The length of time the blood clots were stored did not have
a significant effect on the DNA yield ( p = 0.47).
Discussion
The Maxwell 16 Blood purification kit had a substantially
higher yield than the other commercially available kits tested
as shown in Table 1. The median yield of 4.9 mg DNA from
300 mL frozen archived blood clots was almost comparable to
the 10 mg of DNA yield that can be expected from 300mL
whole blood (Chacon-Cortes et al., 2012). The real-time PCR
results and the A260/A280 ratio show that the DNA purified
with the Maxwell 16 Blood purification kit was of high
Table 1. Yield and A260/A280 Ratio of DNA Extracted from Cryopreserved Clotted
Blood Using Commercial Kits
Method
Blood
(lL)
lg
(median)
Range
(lg)
lg/mL blood
(median)
A260/A280
(median)
Range
(A260/A280)
Real-time PCR
Successful/Total (%)
Maxwell 16 Blood puri-fication
kit (Promega)a
300b 4.90 0.8–25 16.3 1.86 1.66–2.00 40633/41145 (99)
PureGene with glycogen
(Qiagen)
300b 0.65 0.5–2.6 2.2 1.57 1.42–1.68 10/10 (100)
PureGene without glycogen
(Qiagen)
300b 0.60 0.2–1.6 2.0 1.55 1.24–1.68 10/10 (100)
QIAamp DNA Micro kit
(Qiagen)
100 0.55 0.2–1.6 5.5 1.72 1.50–2.02 10/10 (100)
Nucleospin 96 Blood kit
(Macherey-Nagel)
200 0.38 0.1–0.5 1.9 2.01 1.73–2.60 6/6 (100)
aDNA was extracted from 1055 blood clot samples and 39 single-nucleotide polymorphisms (SNPs) were genotyped.
bCan be scaled to larger volumes.
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quality. Furthermore, a pilot study indicated that the DNA
could also be used in genome-wide screening.
There are other inhouse or modified commercial methods
available for extraction of DNA from clotted blood, which are
more cost effective than the Maxwell 16 Blood purification kit
and some have a similar yield (Siafakas et al., 1995; Garg
et al.,1996; Salazar et al., 1998; Basuni et al., 2000; Schunemann
et al., 2000; Adkins et al., 2002; Iovannisci et al., 2006; Se Fum
et al., 2007; Xu et al., 2010; Lundblom et al., 2011). However, the
Maxwell 16 Blood purification kit is the only commercially
available kit, which works out of the box with high-quality
and -quantity DNA yields. Furthermore, the Maxwell 16
Blood purification kit requires very little hands on time as the
method is automated, it does not require experienced labo-
ratory technicians and 64 to 96 samples can be processed in a
work day. Thus, it is well suited for high-throughput purifi-
cation of a large number of samples.
The DNA yield obtained with any of the commercially
available kits tested varied considerably among individuals.
Salazar et al. (1998) found a correlation between leukocyte
counts in blood and DNA concentrations. Unfortunately, we
did not register the leukocyte counts and therefore cannot
perform a similar correlation analysis. Adkins et al. (2002) has
suggested that the variation in yield was due to individual
variation in blood clot formation.
The DNA yield did not depend on how long the blood was
cryopreserved ( p= 0.47), which is supported by Iovannisci
et al. (2006) who also stored blood clots for up to 2.5 years
without an effect on yield. According to Garg et al. (1996), the
freezing of the blood clots had no measurable effect on the
quantity or purity of the DNA extracted. These results show
that DNA can be efficiently extracted from cryopreserved
samples, even after prolonged storage.
Iovannisci et al. (2006) showed that blood clots stored for
up to 12 days at 4C before freezing still gave high yields.
However, Se Fum et al. reported a 100-fold decrease in yield
after storage of blood clots for 1 month at 4C compared to
immediate extraction showing that archived blood clots have
to be frozen (Se Fum et al., 2007).
In conclusion, high-quality and -quantity DNA can be
extracted using the Maxwell 16 Blood purification kit from
cryopreserved archived blood clots. Maxwell is more ex-
pensive than other in-house or modified methods, but it is
simple, fast, and reliable for obtaining high quantities of
DNA. Thus, frozen archived blood clots can be used as a
source of DNA in cases where serum is routinely collected
for clinical tests.
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